en
Scientific article
English

Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration

Published inAnnals of the Rheumatic Diseases, vol. 77, no. 9, p. 1276-1282
Publication date2018
Abstract

To compare the effectiveness of tocilizumab (TCZ) and tumour necrosis factor (TNF) inhibitors (TNFi) as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis (RA) after the use of at least one biologic DMARD (bDMARD).

Citation (ISO format)
LAUPER, Kim et al. Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: analyses from the pan-European TOCERRA register collaboration. In: Annals of the Rheumatic Diseases, 2018, vol. 77, n° 9, p. 1276–1282. doi: 10.1136/annrheumdis-2017-212845
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0003-4967
382views
1downloads

Technical informations

Creation09/03/2018 11:36:00 AM
First validation09/03/2018 11:36:00 AM
Update time03/15/2023 3:09:59 PM
Status update03/15/2023 3:09:58 PM
Last indexation01/17/2024 4:23:18 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack